Participants 763 795 7
36 patients in the control group
Participants 1138 1198 3
72 patients in the Pirarubicin Monotherapy Study Group trial
Participants 1232 1304 4
Among the 31 patients, 17 patients who received pirarubicin instillation
Participants 1346 1388 4
14 patients who received control treatment
